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SUMMARY
Cytomegalovirus (CMV) is a genus in the family Herpesviridae that has been associated with gastrointestinal syndromes. In
this work we looked for a possible association of CMV infection with colorectal cancer and ulcerative colitis (UC). Blood and
enteric tissue samples of 14 patients with colorectal cancer and of 21 with UC were subjected to a nested-PCR that amplifies part
of the gB gene of CMV and also to immunohistochemistry using a specific monoclonal antibody to IE 76kDa protein of CMV.
CMV was detected by nested-PCR in the blood and/or the enteric tissue of nine (64.3%) colorectal cancer and 16 (76.2%)
ulcerative colitis patients. In the immunohistochemistry it was observed that 12 (12/21, 57.1%) positive enteric tissue samples of
patients with UC and none from patients with colorectal cancer (0/14) were positive to CMV. The positivity of CMV infections in
the UC patient group (12/21, 57.1%) showed by both techniques, was significantly higher (p = 0.015) than that observed for
colorectal cancer patients (2/14, 14.3%). These results suggest an association of ulcerative colitis with CMV infection of the
enteric tissue.
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INTRODUCTION
Cytomegalovirus (CMV) is a genus in the β Herpesvirinae subfamily
of the Herpesviridae. CMV is a common causative of gastrointestinal
tract diseases in immunodeficient patients, leading to a high morbidity
and mortality10. CMV disease can occur in all locations of the
gastrointestinal tract, from mouth to rectum and, usually, produces ulcers
in the mucosa, commonly followed by bleeding. CMV has been reported
in the tissues of colorectal cancer, glioma malignant and neoplasm of
prostate8. Besides, CMV genome and proteins have been detected in
cells of solid neoplasms and not at the normal adjacent tissues3,8. However,
the relation of CMV infection with colorectal cancer is still unclear and
divergent. CMV infection has also been described as a causative of
idiopathic ulcerative colitis, a chronic illness of inflammatory nature
and unknown etiology9. Although there have been a gradual increasing
number of case reports of CMV infection complicating ulcerative colitis,
there are few reports on its prevalence19,21.
In the present study we examined blood and enteric tissue samples
of colorectal cancer and ulcerative colitis patients for the presence of
CMV DNA and proteins by PCR and immunohistochemistry tests,
respectively.
MATERIAL AND METHODS
Fourteen individuals with colorectal cancer and 21 individuals with
ulcerative colitis followed, from March 2002 to May 2004, in the
Division of Gastroenterology of the General Hospital of the School of
Medicine of the University of São Paulo in Ribeirão Preto City
(GHSMUSPRP), Brazil, participated of this study. Seven of the
ulcerative colitis participants were receiving immune suppressor drugs
(azathioprine in four patients, and/or parenteral steroid in five) for at
least three months before the sample collection and were considered
as immune suppressed. Whole blood samples were collected by
venipuncture using EDTA as anticoagulant and enteric tissue samples
were obtained by biopsy during endoscopic examination or surgery.
These samples were tested for the presence of CMV genome by nested-
PCR or antigens by immunohistochemistry. This research project was
approved by the Ethic Board of the GHSMUSPRP (Process 3285/2002).
DNA purification: For separation of peripheral blood leukocytes
(PBL), 5 mL of EDTA-treated whole blood samples were processed
immediately after collection. Briefly, 1 mL of 1% dextran was added
to each blood sample and the mixture was incubated at 37 ºC for 30 min.
Ten mL of PBS were added to the supernatant fluids and centrifuged
at 300 g for seven min. The PBL pellets were washed in 10 mL of
PBS, centrifuged and resuspended in 200 µL of PBS. The DNA was
extracted using the QIAamp DNA Blood Kit (Qiagen, Germany),
according to the manufacturer recommendations. The enteric tissue
samples were prepared for DNA extraction by crushing the tissue in
200 µL of PBS. For DNA extraction these samples were processed by
phenol/chloroform method16. Each DNA extract was resuspended in
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200 µL of DNAse/RNAse free water, quantified by spectrophotometry
using the Genequant equipment (Amershan, USA), and stored at -70 ºC
until use.
Nested-PCR: The nested-PCR was carried out as described by
AQUINO et al., 20011. The reaction mixture of the PCR contained, in
a total volume of 50 µL, 75 mM of Tris-HCl (pH 9), 2 mM of MgCl2,
50 mM of KCl, 20 mM of (NH4)2SO4, 50 µM of each one of the
deoxynucleoside triphosphates, 0.3 µM of primers gB1 and gB2 (shown
in Table 1) and 1 µg of DNA obtained from PBLs and enteric tissue.
The reaction mixture was first incubated at 94 ºC for three min, the
temperature was reduced to 80 ºC, and 1U of Taq DNA polymerase
was added. The PCR mixture was subjected to 15 cycles of 60 sec at
94 ºC, 120 sec at 65 ºC, and 120 sec at 72 ºC, and to 30 cycles at 94 ºC
for 60 sec, 55 ºC for 90 sec, 72 ºC for 120 sec, and finally, to three min
at 72 ºC. Two µL of this reaction were used in a nested-PCR containing
the same components mentioned above, except for the internal primers
gBN1 and gBN2 (Table 1). The reaction mixture was first incubated at
94 ºC for three min, the temperature was reduced to 80 ºC, and 1U of
Taq DNA polymerase was added. The PCR mixture was subjected to
30 cycles of 60 sec at 94 ºC, 60 sec at 55 ºC, 60 sec at 72 ºC, and
finally to three min at 72 ºC4. Negative samples were subjected to a
PCR for β-globin gene amplification, as a control for false negative
results, confirming the integrity of DNA extracts and of the reaction
mixture, as well as checking the efficacy of the PCR thermal cycles7.
PCR and nested-PCR products were subjected to electrophoresis in a
2% agarose gel and the amplicon bands were visualized by UV after
ethidium bromide staining.
Immunohistochemistry: All tissue samples have been routinely
fixed in 4% neutral formalin and embedded in paraffin. Briefly, 4-µm-
thick sections were cut from paraffin blocks containing representative
samples. Paraffin sections were de-waxed in xylene, rehydrated through
a series of graded alcohols, placed in 10 mM citrate buffer and submitted
to heat retrieval using a vapor lock for 45 min. After heating, the slides
were allowed to cool to room temperature and briefly washed with
PBS. Endogenous peroxidase activity was blocked with 3% hydrogen
peroxide for five min. Normal serum (Novocastra Universal Quick
Kit, UK) was used for 10 min in order to block nonspecific
immunoassaying. Immunohistochemical staining was performed using
a streptavidin-biotin peroxidase system (Novocastra Universal Quick
Kit, UK). The primary antibody NCL-CMV-IE/EA that recognizes IE
76kDa protein of CMV (1:100, clone DDG9 and CCH2, Novocastra,
UK) was incubated for one h at room temperature. Following washes
in PBS, biotinylated universal secondary antibody (Novocastra
Universal Quick Kit, UK) was applied for 10 min. The sections were
incubated with the streptavidin-biotin complex reagent (Novocastra
Universal Quick Kit, UK) for five min and developed with 3.3-
diaminobenzidine tetrahydrochloride (Liquid DAB Substrate Kit,
Novocastra, UK) for five min. Finally, the slides were counterstained
with hematoxylin of Mayer and mounted with Permount (Fisher
Scientific, USA). Cells with nucleus or edge with brown staining were
considered positive for CMV. The analysis looking for presence of
CMV antigen was only qualitative.
Statistical analysis: The Fisher’s exact test, which is especially
suited for small sets of data, was used with p values equal or under
0.05 to determine the strength of association between the investigated
parameters. Calculations were performed by Instat software (Graph
Pad, USA).
RESULTS
CMV was detected by nested-PCR in the blood and/or the enteric
tissue of nine (64.3%) colorectal cancer and 16 (76.2%) ulcerative
colitis patients. Differences on prevalence of CMV in blood and/or
tissues of the colorectal cancer and ulcerative colitis participants were
not significant, as shown in Table 2.
CMV was detected in nine (64.3%) blood samples and two (14.3%)
enteric tissue samples of patients having colorectal cancer. In the
participants with ulcerative colitis, CMV was detected in the blood
samples of 14 cases (66.7%) and in tissue samples of 11 cases (52.4%)
as shown in Figure 1. Therefore, a higher frequency of CMV was
observed in the blood samples than in the enteric tissue samples by
both techniques and for both studied groups (23/35 or 65.7% and 14/
35 or 40%, respectively) (p = 0.054).
Table 2
Positivity for CMV in blood leukocytes and enteric tissues of
the two groups of patients
Samples Colorectal Ulcerative p value
cancer colitis
Blood 64.3% (9/14) 66.7% (14/21) 1.00
Enteric tissue 14.3% (2/14) 57.1% (12/21) 0.0156
Blood/tissue 64.3% (9/14) 76.2% (16/21) 0.4736
Table 1
Primers used in the PCR and in the nested-PCR for CMV and in the
PCR for β-globin gene
Primer Nucleotide sequence
gB1 5’ GAAACGCGCGGCAATCGG 3’
gB2 5’ TGGAACTGGAACGTTTGGC 3’
gBN1 5’ GCGCCGTTGATCCACACACC 3’
gBN2 5’ TACGCCCAGCTGCAGTTCAC 3’
RS42 5’ GCTCACTCAGTGTGGCAAAG 3’
KM29 5’ GGTTTGGCCAATCTACTCCCAGG 3’
Fig. 1 - Electrophoresis in agarose gel of amplicons (100pb) of nested-PCR for CMV in
enteric tissue of both UC and colorectal cancer patients. L ladder 100pb, lines 1 and 14
control positive, line 16 control negative and lines 2-15 positives CMV.
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The enteric tissue samples of the 14 patients with colorectal cancer
were analyzed by immunohistochemistry for CMV antigens detection
been all of them negative. In the immunohistochemistry of the enteric
tissue samples of the 21 patients with UC, CMV antigens were detected
in epithelial cells of mucosa, 12 (57.1%) cases as shown in Figure 2.
CMV detection in the enteric tissue samples by
immunohistochemistry and PCR showed similar results with the only
exception of one ulcerative colitis participant that had CMV detected
only by immunohistochemistry.
Among the seven patients having ulcerative colitis and in treatment
with immunosuppressive drugs, five (71.4%) had CMV detected in
the enteric tissue samples, while it occurred in only six of 14 (42.9%)
ulcerative colitis participants not using immunosuppressive drugs (p =
0.3615).
The frequency of CMV detected in tissues samples by PCR and/or
immunohistochemistry was significantly higher in the ulcerative colitis
patients (12/21, 57.1%) than in those having colorectal cancer (2/14,
14.3%) (p = 0.0156), as shown in Table 2 and in Figure 3.
DISCUSSION
Gastrointestinal lesions caused by CMV have been increasingly
diagnosed, due to an improvement on diagnostic methods as well as
an increasing on AIDS, transplanted and patients receiving
immunossupressive chemotherapy21. In the present study, CMV was
detected in 65.7% of the blood samples of the participants of the study
independently of the disease. Considering that more than 95% of the
adult population from Ribeirão Preto Region is infected by CMV,
probably, the virus detected in blood leukocytes might not be related
to any enteric disease or even to be in a latent form12,18. Thus, we decided
to exclude these results of our final analysis and conclusions and to
base it only on CMV detection in tissue samples.
Despite various studies showing a role of CMV in the colorectal
cancer, we demonstrated a low frequency of virus in these patients
(14.3%), suggesting no association of CMV with human colorectal
cancer3,8. These results, however, do not exclude the possibility of a
“hit-and-run” hypothesis that claims a virus can mediate cellular
transformation through an initial ‘hit’, while maintenance of the
transformed state is compatible with loss (‘run’) of viral molecules.
Although the concept of hit-and-run transformation has been
controversial, it remains as a plausible explanation for the observations
of neoplasm transformation without virus, following in vitro
transfection of herpesvirus and cytomegalovirus DNAs, which have
been made by multiple laboratories over more than two decades5,17.
Therefore, in our study, the results obtained by the colorectal cancer
group of patients were compared with those from the ulcerative colitis
group.
Since 1961, many authors have reported an association of CMV
infection with ulcerative colitis11,14. However, the frequency of this
association remains unclear. In the present study, CMV was detected
in more than half of the enteric tissues of patients with ulcerative colitis.
The frequency of CMV infection in the ulcerative colitis patient group
was significantly higher than that observed for colorectal cancer patients
suggesting that this virus could be associated to ulcerative colitis. This
higher frequency of CMV in ulcerative colitis patients compared to
colorectal cancer patients, a disease that has also been associated with
CMV infection, make us to suppose that in an ideal comparison, with
control individuals without enteric disease and having an even lower
frequency of CMV, this significant difference would be even greater.
The exact nature of the CMV association with ulcerative colitis is
not clear. It has been suggested that CMV colitis could be a primary
disease that could evolve to ulcerative colitis11,13. ORVAR et al.11
proposed that viral proteins expressed on the cell surface of the CMV
might initiate an autoimmune response in the susceptible host leading
to inflammatory bowel disease. CMV infection in tissue culture cause
direct induction of MHC class I surface antigen expression and cytokine
production of monocytes13,19. It could lead to an autoimmune disorder
and to result in ulcerative colitis. As an alternative explanation for the
presence of CMV in ulcerative colitis tissues, the virus has a propensity
to localize in inflammation areas infecting tissues of granular growth,
such as ulcerative colitis ulcers or to invade areas of mucosa with
preexisting inflammation, but without causing the intestinal
inflammatory illness6,15. Finally, mononuclear cells loading latent phase
CMV could be attracted to the ulcerative colitis inflammation and to
Fig. 2 - Immunohistochemical staining with monoclonal antibody for CMV in enteric tissue
of UC patients. Absence staining in A and B (200 and 400X), and positive staining for CMV
in C and D (200 and 400X).
Fig. 3 - Positivities for CMV observed in enteric tissues of UC and colorectal cancer patients
(* significant difference- p 0.015).
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concentrate locally the viral DNA15. Thus, CMV infection could be a
causative of ulcerative colitis or to occur as a consequence of ulcerative
colitis injuries in the intestinal mucosa.
CMV infection was detected in the enteric tissue of 71.4% (five of
seven) of the immune suppressed ulcerative colitis patients while that
infection occurred in 42.9% (six of 14) of those non immune suppressed
patients of the same group.
We found more than a double of CMV infections in UC enteric
tissues than was reported by TAKAHASHI & TANGE, in Japan, that
found CMV in only 21% of 39 UC enteric biopsies analyzed by
immunohistochemistry19. The higher positivity for CMV observed in
our study, 57%, was confirmed by PCR detection of CMV genome in
the same tissue samples with only one exception. We have no
explanation for this difference of positivity to CMV in enteric tissues
of UC patients of Brazil and of Japan. The larger frequency of enteric
attack by CMV in the immune suppressed has also been reported by
other authors. It could be explained by the opportunistic behavior of
CMV initiating viral replication cycle from previously latent virus13,19.
The reactivation of latent infection by CMV is considered as responsible
for the worsening of ulcerative colitis in some cases reported as resistant
to steroid treatment2,8,19,20.
In short, we observed that CMV was more frequent in ulcerative
colitis than in colorectal cancer tissue, and it suggests an association
between CMV and ulcerative colitis. However, this is an analysis based
on a low casuistic and further studies including larger numbers of
participants are necessary to confirm our data.
RESUMO
Citomegalovírus em câncer coloretal e colite idiopática
ulcerativa
Os Cytomegalovírus (CMV) são um gênero da família
Herpesviridae, que pode estar associado a síndromes gastrointestinais.
No presente trabalho buscamos uma possível associação da infecção
por CMV com câncer coloretal e retocolite ulcerativa (RCU). Amostras
de sangue e tecido entérico de 14 pacientes com câncer coloretal e 21
com RCU foram submetidas a uma nested-PCR que amplifica parte
do gene gB do CMV e a uma imunohistoquímica utilizando um
anticorpo monoclonal específico para proteína IE 76Kda de CMV. CMV
foi detectado pela nested-PCR em sangue e/ou tecido entérico de 9
(64,3%) dos pacientes com câncer coloretal e 16 (76,2%) dos pacientes
com RCU. Na imunohistoquímica foram observadas 12 (57,1%)
amostras positivas para CMV nos pacientes com RCU e nos pacientes
com câncer coloretal o CMV não foi detectado em nenhuma amostra.
A positividade das infecções no grupo de pacientes com RCU (12/21,
57.1%) foi significantemente mais alta (p = 0,015) que aquela observada
nos pacientes com câncer coloretal (2/14, 14.3%). Estes resultados
sugerem uma associação da presença de CMV no tecido entérico com
RCU.
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